CABALETTA BIO, INC. Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax
CABALETTA BIO, INC. (CABA) had Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax of $25.00 thousand as of 2025-12-31, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2026-08-13
- 2025-12-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $25.00K.
- 2025-09-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $26.00K.
- 2025-06-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $1.00K.
- 2024-09-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $1.00K.
| Period end | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2025-12-31 | $25.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $26.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $1.00K 10-Q · filed 2025-08-07 |
| 2024-09-30 | $1.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 |
| 2023-12-31 | $43.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $2.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $16.00K 10-Q · filed 2023-08-10 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-21 |
| 2021-06-30 | $1.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $3.00K 10-Q · filed 2021-05-03 |
| 2020-12-31 | $6.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $12.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $11.00K 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |